SEC Form 4 · accession 0001650664-26-000076
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda Burkly
Officer — EVP, CHIEF SCIENTIFIC OFFICER
Period of report
Jul 28, 2026
Accepted (ET)
Jul 29, 2026 · 4:51 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2026 | S | 4,928 | $2.67 | D | 62,369 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person.